COMP <GO>
HBIO vs QTRX // RETURN ON INVESTED CAPITAL (ROIC)
Harvard Bioscience Inc. (NASDAQ) VS. Quanterix Corporation (NASDAQ) • 15-METRIC TALLY: HBIO 4
— QTRX 2
■ METRIC PARITY
LAST: $8.90 (+1.14%) • MKT CAP: $40.1M
roic
-35.00%
LAST: $2.91 (-7.63%) • MKT CAP: $148.7M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HBIO VS. QTRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HBIO | QTRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.70% | 46.80% | +10.90 | HBIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 13.66% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -56.10% | -60.00% | +3.90 | HBIO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -8.10% | 1.10% | -9.20 | QTRX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | HBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.9 | 53.4 | +11.50 | HBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.1M | $148.7M | -$108.7M | QTRX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HBIO REV | QTRX REV | HBIO GROSS % | QTRX GROSS % | HBIO FCF | QTRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $86.5M | $138.9M | 57.7% | 46.8% | $5.5M | -$79.8M |
| FY 2024 | $94.1M | $137.4M | 58.2% | 60.5% | -$1.2M | -$38.5M |
| FY 2023 | $112.3M | $122.4M | — | — | $14.0M | -$18.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HBIO // BETA —
QTRX // BETA —